H2 antagonists

GG 615 GG 615 Pill - brown capsule-shape, 19mm

Pill with imprint GG 615 GG 615 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Sandoz Pharmaceuticals Inc.

Ranitidine is used in the treatment of Duodenal Ulcer; GERD; Cutaneous Mastocytosis; Erosive Esophagitis; Duodenal Ulcer Prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Ranitidine (Ranitidine [ ra-ni-ti-deen ])-GG 615 GG 615-300 mg-Brown-Capsule-shape
Ranitidine (Ranitidine [ ra-ni-ti-deen ])-GG 615 GG 615-300 mg-Brown-Capsule-shape
Ranitidine (Ranitidine [ ra-ni-ti-deen ])-GG 615 GG 615-300 mg-Brown-Capsule-shape

Ranitidine
Generic Name: ranitidine [ ra-ni-ti-deen ]
Imprint: GG 615 GG 615
Strength: 300 mg
Color: Brown
Size: 19.00 mm
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: H2 antagonists
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00781-2865 (Discontinued)
Inactive Ingredients: Ammonia, Corn starch, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, Gelatin, Magnesium stearate, Propylene glycol, Silicon dioxide, Sodium lauryl sulfate, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs